Nifty
Sensex
:
:
14698.60
49548.83
-398.75 (-2.64%)
-1490.48 (-2.92%)

Pharmaceuticals & Drugs - Domestic

Rating :
66/99

BSE: 506820 | NSE: ASTRAZEN

3505.60
25-Feb-2021
  • Open
  • High
  • Low
  • Previous Close
  •  3535.85
  •  3535.85
  •  3500.00
  •  3485.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  15028
  •  528.56
  •  4970.00
  •  1885.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,771.38
  • 116.02
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,518.85
  • 0.03%
  • 21.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.52%
  • 18.30%
  • FII
  • DII
  • Others
  • 2.36%
  • 1.39%
  • 1.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 8.09
  • 13.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 49.03
  • 21.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 68.86
  • 40.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 90.98
  • 115.96
  • 118.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.57
  • 23.57
  • 23.57

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 47.86
  • 61.93
  • 62.37

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma gets import, market permission for Benralizumab solution for injection
    21st Dec 2020, 09:41 AM

    The receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.